ECLINSO is an innovative provider of Clinical Technology solutions and support services to enhance the conduct of clinical trials globally. Its trialforce end-to-end platform is easy to deploy, accessible and scalable.
trialforce offers unparalleled flexibility and adaptability to both sponsors and clinical research organizations (CRO’s); there is no local software or hardware to support. It is a fully managed platform and compliant with industry standards 21 CFR 11, CDISC, HIPAA, W3C, and GCP; it supports over 50 languages (including double byte languages such as Chinese).
Offering trialforce as a subscription based service saves time and cost in study deployment – ECLINSO eliminates the need for multiple vendors, software solutions and support by offering one single platform.
The trialforce platform eliminates unnecessary steps and will optimize performance and efficiency in any process. It combines best- in-class software to deliver an end-to-end solution:
Eliminates redundancies and increases efficiencies
ECLINSO provides a comprehensive program for CRO’s which includes:
With over 15 years’ experience supporting eClinical software and other technology solutions in clinical studies ECLINSO approaches each project with the commitment to exceed client expectations.
ECLINSO AG St. Jakobs-Strasse 199 CH-4052 Basel Switzerland Tel – +41 60 666 64 01 |
ECLINSO US (East) 160 Chubb Ave., Suite 206 Lyndhurst, NJ 07071 United States Tel – +1 201 372 1465 |
ECLINSO US (West) 1651 Calle Leticia San Diego, CA 93037 United States Tel +1 855-245-0987 |
Email: info@eclinso.com
URL: www.eclinso.com